(Q37847698)

24 August 2017

title

Prevalence, incidence and persistence of genital HPV infections in a large cohort of sexually active young women in the Netherlands (English)

1 reference

sexually transmitted infection

24 August 2017

main subject

0 references

Netherlands

0 references

author name string

M Mollers

1

1 reference

24 August 2017

J Boot Hein

2

1 reference

24 August 2017

J Vriend Henrike

3

1 reference

24 August 2017

J King Audrey

4

1 reference

24 August 2017

V F van den Broek Ingrid

5

1 reference

24 August 2017

E A M van Bergen Jan

6

1 reference

24 August 2017

A T P Brink Antoinette

7

1 reference

24 August 2017

F G Wolffs Petra

8

1 reference

24 August 2017

J P A Hoebe Christian

9

1 reference

24 August 2017

J L M Meijer Chris

10

1 reference

24 August 2017

A B van der Sande Marianne

11

1 reference

24 August 2017

E de Melker Hester

12

1 reference

24 August 2017

language of work or name

English

0 references

publication date

10 November 2012

1 reference

24 August 2017

1 reference

24 August 2017

volume

31

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

394-401

1 reference

Epidemiology of Genital Human Papillomavirus Infection

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

The evolving definition of carcinogenic human papillomavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Rationale, design, and results of the first screening round of a comprehensive, register-based, Chlamydia screening implementation programme in the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Evaluation design of a systematic, selective, internet-based, Chlamydia screening implementation in the Netherlands, 2008-2010: implications of first results for the analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Systematic selection of screening participants by risk score in a Chlamydia screening programme is feasible and effective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Quantitation of viral load using real-time amplification techniques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

A review of human carcinogens--Part B: biological agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Marginal and mixed-effects models in the analysis of human papillomavirus natural history data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Cervical human papillomavirus screening among older women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Alternating high-risk human papillomavirus infection: consequences of progression to cervical intraepithelial neoplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Influence of partner's infection status on prevalent human papillomavirus among persons with a new sex partner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Higher levels of cervicovaginal inflammatory and regulatory cytokines and chemokines in healthy young women with immature cervical epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Factors affecting the detection rate of human papillomavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Concordance of self-collected and clinician-collected swab samples for detecting human papillomavirus DNA in women 18 to 32 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.087

10.1016/J.VACCINE.2012.10.087

7 January 2021

Identifiers

DOI

1 reference

24 August 2017

1 reference